Oliver Lagore Vanvalin Investment Group Increases Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Oliver Lagore Vanvalin Investment Group raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 12.6% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 214 shares of the healthcare conglomerate’s stock after acquiring an additional 24 shares during the period. Oliver Lagore Vanvalin Investment Group’s holdings in UnitedHealth Group were worth $113,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in the stock. Kraft Davis & Associates LLC grew its holdings in shares of UnitedHealth Group by 3.4% in the third quarter. Kraft Davis & Associates LLC now owns 577 shares of the healthcare conglomerate’s stock valued at $294,000 after purchasing an additional 19 shares in the last quarter. Iron Horse Wealth Management LLC grew its holdings in shares of UnitedHealth Group by 1.6% in the third quarter. Iron Horse Wealth Management LLC now owns 1,217 shares of the healthcare conglomerate’s stock valued at $614,000 after purchasing an additional 19 shares in the last quarter. Secure Asset Management LLC grew its holdings in shares of UnitedHealth Group by 0.8% in the third quarter. Secure Asset Management LLC now owns 2,456 shares of the healthcare conglomerate’s stock valued at $1,238,000 after purchasing an additional 19 shares in the last quarter. Bensler LLC grew its holdings in shares of UnitedHealth Group by 0.3% in the third quarter. Bensler LLC now owns 7,293 shares of the healthcare conglomerate’s stock valued at $3,677,000 after purchasing an additional 19 shares in the last quarter. Finally, Texas Capital Bancshares Inc TX grew its holdings in shares of UnitedHealth Group by 1.1% in the third quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock valued at $855,000 after purchasing an additional 19 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several research analysts have commented on UNH shares. TD Cowen dropped their price objective on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a research note on Wednesday, April 10th. Truist Financial reaffirmed a “buy” rating and set a $600.00 price objective on shares of UnitedHealth Group in a research note on Wednesday. Stephens reaffirmed an “overweight” rating and set a $605.00 price objective on shares of UnitedHealth Group in a research note on Thursday, February 8th. Bank of America reaffirmed a “buy” rating and set a $675.00 price objective on shares of UnitedHealth Group in a research note on Thursday, March 7th. Finally, Royal Bank of Canada decreased their target price on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a research report on Wednesday. Four equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $570.05.

UnitedHealth Group Stock Performance

UNH stock opened at $493.16 on Friday. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. The business has a 50-day moving average price of $488.97 and a 200 day moving average price of $515.22. The company has a market capitalization of $454.66 billion, a P/E ratio of 30.14, a PEG ratio of 1.31 and a beta of 0.54. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. During the same period in the previous year, the company posted $6.26 earnings per share. The firm’s quarterly revenue was up 8.6% on a year-over-year basis. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 27.74 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a yield of 1.52%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 45.97%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.